Trial Profile
Pilot Open-label Study of the Effect of Etanercept on Vascular Inflammation in Patients With Active Rheumatoid Arthritis
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 06 Feb 2017 Status changed from active, no longer recruiting to discontinued due to Recruitment difficulties.
- 15 Sep 2016 Planned End Date changed from 1 Dec 2018 to 1 Nov 2016.
- 15 Sep 2016 Planned primary completion date changed from 1 Nov 2018 to 1 Nov 2016.